Diabetic Perspectives

Genetic Susceptibility to Type 1 Diabetes in the Intracellular Pathway of Antigen Processing – A Subject Review and Cross-Study Comparison

Charles Sia¹, ²

Keywords: type 1 diabetes, T cell receptor, antigen presentation, TAP, LMP

Abstract

Ligand binding grooves of MHC class I molecules are able to load a panel of endogenous peptides of varying length and sequence derived from self or foreign origin to activate or deactivate cytotoxic CD8⁺ T cells. Peptides are assembled with class I molecules by pathways that are either dependent or independent of transport by ABC proteins (TAP) and degradation in the immunoproteasome by its subunits LMP2 and LMP7. Those peptides that require TAP and LMP treatment appear to be subject to control and optimization by TAP for proper customizing and efficient presentation. Therefore, allelic variations in the coding sequences of TAP and LMP were suspected for a long time to be responsible for improper antigen processing, interruption of self-peptide presentation and reduced cell surface expression of MHC class I molecules resulting in the activation of autoreactive CD8⁺ T cells. In this article we reviewed the controversial findings regarding the role of TAP and LMP genes in autoimmune diabetes and reevaluated data of eleven separate studies in a cross-study analysis by genotype and HLA haplotype matching. We could confirm previous results by showing that TAP2*651-A/F and TAP2*687-A/A are significantly associated with disease, independently of linkage disequilibrium (LD). LMP2-R/H surprisingly seems to be primarily disease-conferring although a weak association with DR4 serotypes can be observed. Our analysis also suggests that LMP7-B/B, TAP1-A/A and TAP2*687-A/B are the protective genotypes and that these associations are not secondary to LD with DRB1. Consequently, intracellular antigen processing associated with TAP- and proteasome-dependent pathways seems to be a critical element in T cell selection for the retention of a balanced immunity.

Fulltext: HTML , PDF (1.3 MB)

This article has been cited by other articles:

	The type 1 diabetes - HLA susceptibility interactome - identification of HLA genotype-specific disease genes for type 1 diabetes Brorsson C, Tue Hansen N, Bergholdt R, Brunak S, Pociot F PLoS One 2010. 5(3):e9576
	Long-term and acute effects of gliadin on small intestine of patients on potentially pathogenic networks in celiac disease Castellanos-Rubio A, Santin I, Martin-Pagola A, Irastorza I, Castano L, Vitoria JC, Bilbao JR Autoimmunity 2010. 43(2):131-139
	Genetic deficiency of Itgb2 or ItgaL prevents autoimmune diabetes through distinctly different mechanisms in NOD/LtJ mice Glawe JD, Patrick DR, Huang M, Sharp CD, Barlow SC, Kevil CG Diabetes 2009. 58(6):1292-1301
	HLA and infectious diseases Blackwell JM, Jamieson SE, Burgner D Clin Microbiol Rev 2009. 22(2):370-385
	Multiple Drug Resistance Associated with Function of ABC-Transporters in Diabetes Mellitus: Molecular Mechanism and Clinical Relevance Koehn J, Fountoulakis M, Krapfenbauer K Infect Disord Drug Targets 2008. 8(2):109-118
	Prediction of autoimmune diseases: myth, reality and risk Ortega-Hernandez OD, Lopez-Guzman S, Rojas-Villarraga A, Anaya JM Rev Fac Med 2008. 16(1):56-73
	Death Pathways in T Cell Homeostasis and Their Role in Autoimmune Diabetes Gronski MA, Weinem M Rev Diabet Stud 2006. 3(2):88-95
	The role of HLA class I gene variation in autoimmune diabetes Sia C, Weinem M Rev Diabet Stud 2005. 2(2):97-109